Adalimumab Market

Global Adalimumab Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Jul, 2019 | Report ID: 75616 | 118 | Pharmaceuticals and Healthcare
Adalimumab, sold under the trade name Humira among others, is a medication used to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, chronic psoriasis, hidradenitis suppurativa, and juvenile idiopathic arthritis.

Scope of the Report:
The worldwide market for Adalimumab is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
This report focuses on the Adalimumab in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
AbbVie
Amgen
Sandoz
Boehringer Ingelheim
Mylan
Biogen

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Adalimumab
Adalimumab Biosimilar

Market Segment by Applications, can be divided into
Adults
Children


There are 15 Chapters to deeply display the global Adalimumab market.
Chapter 1, to describe Adalimumab Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Adalimumab, with sales, revenue, and price of Adalimumab, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Adalimumab, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Adalimumab market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Adalimumab sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents



1 Market Overview

1.1 Adalimumab Introduction

1.2 Market Analysis by Type

1.2.1 Adalimumab

1.2.2 Adalimumab Biosimilar

1.3 Market Analysis by Applications

1.3.1 Adults

1.3.2 Children

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 AbbVie

2.1.1 Business Overview

2.1.2 Adalimumab Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 AbbVie Adalimumab Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Amgen

2.2.1 Business Overview

2.2.2 Adalimumab Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Amgen Adalimumab Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Sandoz

2.3.1 Business Overview

2.3.2 Adalimumab Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Sandoz Adalimumab Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Boehringer Ingelheim

2.4.1 Business Overview

2.4.2 Adalimumab Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Boehringer Ingelheim Adalimumab Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Mylan

2.5.1 Business Overview

2.5.2 Adalimumab Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Mylan Adalimumab Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Biogen

2.6.1 Business Overview

2.6.2 Adalimumab Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Biogen Adalimumab Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Adalimumab Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Adalimumab Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Adalimumab Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Adalimumab Manufacturer Market Share in 2017

3.3.2 Top 6 Adalimumab Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Adalimumab Market Analysis by Regions

4.1 Global Adalimumab Sales, Revenue and Market Share by Regions

4.1.1 Global Adalimumab Sales and Market Share by Regions (2013-2018)

4.1.2 Global Adalimumab Revenue and Market Share by Regions (2013-2018)

4.2 North America Adalimumab Sales and Growth Rate (2013-2018)

4.3 Europe Adalimumab Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Adalimumab Sales and Growth Rate (2013-2018)

4.5 South America Adalimumab Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Adalimumab Sales and Growth Rate (2013-2018)

5 North America Adalimumab by Countries

5.1 North America Adalimumab Sales, Revenue and Market Share by Countries

5.1.1 North America Adalimumab Sales and Market Share by Countries (2013-2018)

5.1.2 North America Adalimumab Revenue and Market Share by Countries (2013-2018)

5.2 United States Adalimumab Sales and Growth Rate (2013-2018)

5.3 Canada Adalimumab Sales and Growth Rate (2013-2018)

5.4 Mexico Adalimumab Sales and Growth Rate (2013-2018)

6 Europe Adalimumab by Countries

6.1 Europe Adalimumab Sales, Revenue and Market Share by Countries

6.1.1 Europe Adalimumab Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Adalimumab Revenue and Market Share by Countries (2013-2018)

6.2 Germany Adalimumab Sales and Growth Rate (2013-2018)

6.3 UK Adalimumab Sales and Growth Rate (2013-2018)

6.4 France Adalimumab Sales and Growth Rate (2013-2018)

6.5 Russia Adalimumab Sales and Growth Rate (2013-2018)

6.6 Italy Adalimumab Sales and Growth Rate (2013-2018)

7 Asia-Pacific Adalimumab by Countries

7.1 Asia-Pacific Adalimumab Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Adalimumab Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Adalimumab Revenue and Market Share by Countries (2013-2018)

7.2 China Adalimumab Sales and Growth Rate (2013-2018)

7.3 Japan Adalimumab Sales and Growth Rate (2013-2018)

7.4 Korea Adalimumab Sales and Growth Rate (2013-2018)

7.5 India Adalimumab Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Adalimumab Sales and Growth Rate (2013-2018)

8 South America Adalimumab by Countries

8.1 South America Adalimumab Sales, Revenue and Market Share by Countries

8.1.1 South America Adalimumab Sales and Market Share by Countries (2013-2018)

8.1.2 South America Adalimumab Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Adalimumab Sales and Growth Rate (2013-2018)

8.3 Argentina Adalimumab Sales and Growth Rate (2013-2018)

8.4 Colombia Adalimumab Sales and Growth Rate (2013-2018)

9 Middle East and Africa Adalimumab by Countries

9.1 Middle East and Africa Adalimumab Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Adalimumab Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Adalimumab Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Adalimumab Sales and Growth Rate (2013-2018)

9.3 UAE Adalimumab Sales and Growth Rate (2013-2018)

9.4 Egypt Adalimumab Sales and Growth Rate (2013-2018)

9.5 Nigeria Adalimumab Sales and Growth Rate (2013-2018)

9.6 South Africa Adalimumab Sales and Growth Rate (2013-2018)

10 Global Adalimumab Market Segment by Type

10.1 Global Adalimumab Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Adalimumab Sales and Market Share by Type (2013-2018)

10.1.2 Global Adalimumab Revenue and Market Share by Type (2013-2018)

10.2 Adalimumab Sales Growth and Price

10.2.1 Global Adalimumab Sales Growth (2013-2018)

10.2.2 Global Adalimumab Price (2013-2018)

10.3 Adalimumab Biosimilar Sales Growth and Price

10.3.1 Global Adalimumab Biosimilar Sales Growth (2013-2018)

10.3.2 Global Adalimumab Biosimilar Price (2013-2018)

11 Global Adalimumab Market Segment by Application

11.1 Global Adalimumab Sales Market Share by Application (2013-2018)

11.2 Adults Sales Growth (2013-2018)

11.3 Children Sales Growth (2013-2018)

12 Adalimumab Market Forecast (2018-2023)

12.1 Global Adalimumab Sales, Revenue and Growth Rate (2018-2023)

12.2 Adalimumab Market Forecast by Regions (2018-2023)

12.2.1 North America Adalimumab Market Forecast (2018-2023)

12.2.2 Europe Adalimumab Market Forecast (2018-2023)

12.2.3 Asia-Pacific Adalimumab Market Forecast (2018-2023)

12.2.4 South America Adalimumab Market Forecast (2018-2023)

12.2.5 Middle East and Africa Adalimumab Market Forecast (2018-2023)

12.3 Adalimumab Market Forecast by Type (2018-2023)

12.3.1 Global Adalimumab Sales Forecast by Type (2018-2023)

12.3.2 Global Adalimumab Market Share Forecast by Type (2018-2023)

12.4 Adalimumab Market Forecast by Application (2018-2023)

12.4.1 Global Adalimumab Sales Forecast by Application (2018-2023)

12.4.2 Global Adalimumab Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures



Figure Adalimumab Picture

Table Product Specifications of Adalimumab

Figure Global Sales Market Share of Adalimumab by Types in 2017

Table Adalimumab Types for Major Manufacturers

Figure Adalimumab Picture

Figure Adalimumab Biosimilar Picture

Figure Adalimumab Sales Market Share by Applications in 2017

Figure Adults Picture

Figure Children Picture

Figure United States Adalimumab Revenue (Value) and Growth Rate (2013-2023)

Figure Canada Adalimumab Revenue (Value) and Growth Rate (2013-2023)

Figure Mexico Adalimumab Revenue (Value) and Growth Rate (2013-2023)

Figure Germany Adalimumab Revenue (Value) and Growth Rate (2013-2023)

Figure France Adalimumab Revenue (Value) and Growth Rate (2013-2023)

Figure UK Adalimumab Revenue (Value) and Growth Rate (2013-2023)

Figure Russia Adalimumab Revenue (Value) and Growth Rate (2013-2023)

Figure Italy Adalimumab Revenue (Value) and Growth Rate (2013-2023)

Figure China Adalimumab Revenue (Value) and Growth Rate (2013-2023)

Figure Japan Adalimumab Revenue (Value) and Growth Rate (2013-2023)

Figure Korea Adalimumab Revenue (Value) and Growth Rate (2013-2023)

Figure India Adalimumab Revenue (Value) and Growth Rate (2013-2023)

Figure Southeast Asia Adalimumab Revenue (Value) and Growth Rate (2013-2023)

Figure Brazil Adalimumab Revenue (Value) and Growth Rate (2013-2023)

Figure Egypt Adalimumab Revenue (Value) and Growth Rate (2013-2023)

Figure Saudi Arabia Adalimumab Revenue (Value) and Growth Rate (2013-2023)

Figure South Africa Adalimumab Revenue (Value) and Growth Rate (2013-2023)

Figure Nigeria Adalimumab Revenue (Value) and Growth Rate (2013-2023)

Table AbbVie Basic Information, Manufacturing Base and Competitors

Table AbbVie Adalimumab Type and Applications

Table AbbVie Adalimumab Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Amgen Basic Information, Manufacturing Base and Competitors

Table Amgen Adalimumab Type and Applications

Table Amgen Adalimumab Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Sandoz Basic Information, Manufacturing Base and Competitors

Table Sandoz Adalimumab Type and Applications

Table Sandoz Adalimumab Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors

Table Boehringer Ingelheim Adalimumab Type and Applications

Table Boehringer Ingelheim Adalimumab Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Mylan Basic Information, Manufacturing Base and Competitors

Table Mylan Adalimumab Type and Applications

Table Mylan Adalimumab Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Biogen Basic Information, Manufacturing Base and Competitors

Table Biogen Adalimumab Type and Applications

Table Biogen Adalimumab Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Global Adalimumab Sales by Manufacturer (2016-2017)

Figure Global Adalimumab Sales Market Share by Manufacturer in 2016

Figure Global Adalimumab Sales Market Share by Manufacturer in 2017

Table Global Adalimumab Revenue by Manufacturer (2016-2017)

Figure Global Adalimumab Revenue Market Share by Manufacturer in 2016

Figure Global Adalimumab Revenue Market Share by Manufacturer in 2017

Figure Top 3 Adalimumab Manufacturer (Revenue) Market Share in 2017

Figure Top 6 Adalimumab Manufacturer (Revenue) Market Share in 2017

Figure Global Adalimumab Sales and Growth Rate (2013-2018)

Figure Global Adalimumab Revenue and Growth Rate (2013-2018)

Table Global Adalimumab Sales by Regions (2013-2018)

Table Global Adalimumab Sales Market Share by Regions (2013-2018)

Table Global Adalimumab Revenue by Regions (2013-2018)

Figure Global Adalimumab Revenue Market Share by Regions in 2013

Figure Global Adalimumab Revenue Market Share by Regions in 2017

Figure North America Adalimumab Sales and Growth Rate (2013-2018)

Figure Europe Adalimumab Sales and Growth Rate (2013-2018)

Figure Asia-Pacific Adalimumab Sales and Growth Rate (2013-2018)

Figure South America Adalimumab Sales and Growth Rate (2013-2018)

Figure Middle East and Africa Adalimumab Sales and Growth Rate (2013-2018)

Figure North America Adalimumab Revenue and Growth Rate (2013-2018)

Table North America Adalimumab Sales by Countries (2013-2018)

Table North America Adalimumab Sales Market Share by Countries (2013-2018)

Figure North America Adalimumab Sales Market Share by Countries in 2013

Figure North America Adalimumab Sales Market Share by Countries in 2017

Table North America Adalimumab Revenue by Countries (2013-2018)

Table North America Adalimumab Revenue Market Share by Countries (2013-2018)

Figure North America Adalimumab Revenue Market Share by Countries in 2013

Figure North America Adalimumab Revenue Market Share by Countries in 2017

Figure United States Adalimumab Sales and Growth Rate (2013-2018)

Figure Canada Adalimumab Sales and Growth Rate (2013-2018)

Figure Mexico Adalimumab Sales and Growth Rate (2013-2018)

Figure Europe Adalimumab Revenue and Growth Rate (2013-2018)

Table Europe Adalimumab Sales by Countries (2013-2018)

Table Europe Adalimumab Sales Market Share by Countries (2013-2018)

Table Europe Adalimumab Revenue by Countries (2013-2018)

Figure Europe Adalimumab Revenue Market Share by Countries in 2016

Figure Europe Adalimumab Revenue Market Share by Countries in 2017

Figure Germany Adalimumab Sales and Growth Rate (2013-2018)

Figure UK Adalimumab Sales and Growth Rate (2013-2018)

Figure France Adalimumab Sales and Growth Rate (2013-2018)

Figure Russia Adalimumab Sales and Growth Rate (2013-2018)

Figure Italy Adalimumab Sales and Growth Rate (2013-2018)

Figure Asia-Pacific Adalimumab Revenue and Growth Rate (2013-2018)

Table Asia-Pacific Adalimumab Sales by Countries (2013-2018)

Table Asia-Pacific Adalimumab Sales Market Share by Countries (2013-2018)

Figure Asia-Pacific Adalimumab Sales Market Share by Countries 2017

Table Asia-Pacific Adalimumab Revenue by Countries (2013-2018)

Figure Asia-Pacific Adalimumab Revenue Market Share by Countries 2017

Figure China Adalimumab Sales and Growth Rate (2013-2018)

Figure Japan Adalimumab Sales and Growth Rate (2013-2018)

Figure Korea Adalimumab Sales and Growth Rate (2013-2018)

Figure India Adalimumab Sales and Growth Rate (2013-2018)

Figure Southeast Asia Adalimumab Sales and Growth Rate (2013-2018)

Figure South America Adalimumab Revenue and Growth Rate (2013-2018)

Table South America Adalimumab Sales by Countries (2013-2018)

Table South America Adalimumab Sales Market Share by Countries (2013-2018)

Figure South America Adalimumab Sales Market Share by Countries in 2017

Table South America Adalimumab Revenue by Countries (2013-2018)

Table South America Adalimumab Revenue Market Share by Countries (2013-2018)

Figure South America Adalimumab Revenue Market Share by Countries in 2017

Figure Brazil Adalimumab Sales and Growth Rate (2013-2018)

Figure Argentina Adalimumab Sales and Growth Rate (2013-2018)

Figure Colombia Adalimumab Sales and Growth Rate (2013-2018)

Figure Middle East and Africa Adalimumab Revenue and Growth Rate (2013-2018)

Table Middle East and Africa Adalimumab Sales by Countries (2013-2018)

Table Middle East and Africa Adalimumab Sales Market Share by Countries (2013-2018)

Figure Middle East and Africa Adalimumab Sales Market Share by Countries in 2017

Table Middle East and Africa Adalimumab Revenue by Countries (2013-2018)

Table Middle East and Africa Adalimumab Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Adalimumab Revenue Market Share by Countries in 2013

Figure Middle East and Africa Adalimumab Revenue Market Share by Countries in 2017

Figure Saudi Arabia Adalimumab Sales and Growth Rate (2013-2018)

Figure UAE Adalimumab Sales and Growth Rate (2013-2018)

Figure Egypt Adalimumab Sales and Growth Rate (2013-2018)

Figure Nigeria Adalimumab Sales and Growth Rate (2013-2018)

Figure South Africa Adalimumab Sales and Growth Rate (2013-2018)

Table Global Adalimumab Sales by Type (2013-2018)

Table Global Adalimumab Sales Share by Type (2013-2018)

Table Global Adalimumab Revenue by Type (2013-2018)

Table Global Adalimumab Revenue Share by Type (2013-2018)

Figure Global Adalimumab Sales Growth (2013-2018)

Figure Global Adalimumab Price (2013-2018)

Figure Global Adalimumab Biosimilar Sales Growth (2013-2018)

Figure Global Adalimumab Biosimilar Price (2013-2018)

Table Global Adalimumab Sales by Application (2013-2018)

Table Global Adalimumab Sales Share by Application (2013-2018)

Figure Global Children Sales Growth (2013-2018)

Figure Global Adalimumab Sales, Revenue and Growth Rate (2018-2023)

Table Global Adalimumab Sales Forecast by Regions (2018-2023)

Table Global Adalimumab Market Share Forecast by Regions (2018-2023)

Figure North America Sales Adalimumab Market Forecast (2018-2023)

Figure Europe Sales Adalimumab Market Forecast (2018-2023)

Figure Asia-Pacific Sales Adalimumab Market Forecast (2018-2023)

Figure South America Sales Adalimumab Market Forecast (2018-2023)

Figure Middle East and Africa Sales Adalimumab Market Forecast (2018-2023)

Table Global Adalimumab Sales Forecast by Type (2018-2023)

Table Global Adalimumab Market Share Forecast by Type (2018-2023)

Table Global Adalimumab Sales Forecast by Application (2018-2023)

Table Global Adalimumab Market Share Forecast by Application (2018-2023)

Table Distributors/Traders/ Dealers List

Sample Request is not available

Shop Now

Buy Now

Quick Contact

+1